Tetracosa-6,9,12,15,18,21-hexaenoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Tetracosa-6,9,12,15,18,21-hexaenoic acid
• 化学式: C₂₄H₃₆O₂
• 分子量: 356.5
• InChiKey: YHGJECVSSKXFCJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.1
• 重原子数：
  26
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] SMALL MOLECULE COMPOUNDS TO SUPPORT HEALTHY HUMAN AGING<br/>[FR] COMPOSÉS À PETITES MOLÉCULES POUR FAVORISER UN VIEILLISSEMENT HUMAIN SAIN
  申请人：CARDAX PHARMA INC

  公开号：WO2018183353A1

  公开（公告）日：2018-10-04

  Disclosed herein are methods of activating expression of the FOXO3 gene in a subject comprising administering to a subject small molecule compound (such as astaxanthin and/or one or more astaxanthin derivatives), or pharmaceutically acceptable salts thereof, in an amount sufficient to at least partially increase the amount of FoxO3 expressed in the subject.

  本文揭示了一种激活主体中FOXO3基因表达的方法，包括向主体施用小分子化合物（如虾青素和/或一个或多个虾青素衍生物）或其药用可接受盐，以足够数量至少部分增加主体中表达的FoxO3的方法。
• [EN] FATTY ACID DERIVATIVES OF CATECHINS AND METHODS OF THEIR USE<br/>[FR] DÉRIVÉS D'ACIDES GRAS DE CATÉCHINES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：GENESIS GROUP INC

  公开号：WO2011123942A1

  公开（公告）日：2011-10-13

  The present disclosure relates to fatty acid derivatives of green tea catechins including epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC), epigallocatechin gallate (EGCG) and their epimers (e.g. catechin, catechin gallate, gallocatechin, gallocatechin gallate) or their mixtures and/or green tea extracts.

  本公开涉及绿茶儿茶素的脂肪酸衍生物，包括表儿茶素（EC）、表儿茶素没食子酸酯（ECG）、表儿茶素（EGC）、表儿茶素没食子酸酯（EGCG）及其外消旋异构体（例如儿茶素、儿茶素没食子酸酯、没食子儿茶素、没食子儿茶素酸酯）或它们的混合物和/或绿茶提取物。
• Micelles For Drug Delivery
  申请人：Yang Yi-Yan

  公开号：US20100159019A1

  公开（公告）日：2010-06-24

  The invention provides a block copolymer comprising at least a first block and a second block. The first block comprises a plurality of temperature-sensitive monomeric units, a plurality of hydrophilic monomeric units and a plurality of targeting monomeric units, and the second block comprises a plurality of hydrophobic monomeric units. The second block comprises at least one pH-sensitive moiety.

  本发明提供了一种嵌段共聚物，包括至少第一嵌段和第二嵌段。第一嵌段包括多个温度敏感单体单元、多个亲水性单体单元和多个定位单体单元，第二嵌段包括多个疏水性单体单元。第二嵌段包括至少一个pH敏感基团。
• [EN] COMPOSITIONS COMPRISING AN UROLITHIN COMPOUND<br/>[FR] COMPOSITIONS COMPRENANT UN COMPOSÉ UROLITHINE
  申请人：AMAZENTIS SA

  公开号：WO2017036993A1

  公开（公告）日：2017-03-09

  The invention provides compositions comprising a source of protein and a urolithin. The invention also provides uses and methods associated with, or making use of the compositions, such as a medicament, dietary supplement, functional food or medical food and in the treatment and/or prophylaxis of a muscle-related pathological condition. The invention also provides kits comprising urolithin and protein.

  本发明提供了包含蛋白质来源和尿石素的组合物。本发明还提供了与该组合物相关的用途和方法，例如药物、膳食补充剂、功能性食品或医疗食品，以及在治疗和/或预防肌肉相关病理状况方面的用途。本发明还提供了包含尿石素和蛋白质的试剂盒。
• [EN] COMPOSITIONS COMPRISING UROLITHIN COMPOUNDS<br/>[FR] COMPOSITIONS COMPRENANT DES COMPOSÉS D'UROLITHINE
  申请人：AMAZENTIS SA

  公开号：WO2017036992A1

  公开（公告）日：2017-03-09

  The invention provides compositions comprising a medium chain triglyceride and a urolithin. The invention also provides uses and methods associated with, or making use of the compositions,such as a medicament, dietary supplement, functional food or medical food and in the treatment and/or prophylaxis of a muscle-related pathological condition.

  本发明提供了包含中链甘油三酯和尿石素的组合物。本发明还提供了与该组合物相关的用途和方法，例如药物、膳食补充剂、功能性食品或医疗食品，以及治疗和/或预防与肌肉相关的病理性状的方法。